The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

Donald Trump’s pick for Health and Human Services Secretary could have been using Zyn, young people’s ‘favourite drug’ ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.